Multicomponent Meningococcal Vaccine

Abstract

A composition is provided comprising N. meningitidis outer membrane vesicles, wherein said outer membrane vesicles are enriched with at least one antigenic component. The composition is suitable for use in vaccines and for treatment of infection, particularly meningococcal infection, demonstrating a broad spectrum of protection. A number of preferred antigenic components are described and include antigenic proteins and proteoglycans derived from N. meningitidis.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 10, 2011
  • Application: Apr 12, 2010
    US US 75831510 A
  • Priority: Apr 12, 2010
    US US 75831510 A
  • Priority: Oct 20, 2008
    US US 28909808 A
  • Priority: Dec 17, 2002
    US US 32080002 A
  • Priority: Aug 29, 2001
    US US 83085401 A
  • Priority: Nov 2, 1999
    GB GB 9903626 W
  • Priority: Nov 2, 1998
    GB GB 9823978 A

Download Citation


Sign in to the Lens

Feedback